Product Code: ETC051364 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India Gastrointestinal Drugs Market was valued at approximately USD 2.6 billion in 2025 and is expected to grow at a CAGR of 5.1% during the forecast period from 2025 to 2031. This growth is majorly driven by increasing prevalence of gastrointestinal diseases such as irritable bowel syndrome (IBS), peptic ulcer disease, indigestion, gastroesophageal reflux disease (GERD), inflammatory bowel disorder (IBD) among others. Additionally, growing awareness about GI drugs and rising healthcare expenditure are also contributing to the growth of this market in India. Moreover, government initiatives towards providing better healthcare facilities for GI disorders is likely to further drive the market growth over the next few years.
Growing Prevalence of Gastrointestinal Diseases: Increasing cases of digestive problems worldwide has fuelled demand for effective treatments leading to increased consumption of gastrointestinal drugs across all regions including India over the past few years. In addition, according to an article published on World Health Organization website in 2025 stated that around 5-25 percent people suffer from IBD or other related disorders globally which requires treatment either with medication or surgery depending upon severity level thereby propelling demand for respective medications driving overall market size & share during estimated timeframe from 2025-2031. Government initiatives like Prime Minister?s National Health Protection Scheme focused on providing health insurance coverage up to INR 500000 per family annually have been beneficial for patients suffering from chronic gastric issues who require prolonged medical attention and expensive treatments thus encouraging them financially towards availing best medicines & therapies available so far leading industry expansion between 2025 & 2031 both domestically as well as internationally across various countries.
High Cost Involved In Development Of New Drugs And Complex Regulatory Framework For Approval Of Existing Ones : The high cost required for development of new drugs due lack availability natural resources along with complex regulatory framework involved approval existing ones even after successful clinical trials hinder overall production rate resulting into limited availability products within affordable pricing options creating roadblocks industry progress between projected timeline . Lack awareness regarding available treatment options among population especially rural areas often leads incorrect diagnosis misdiagnosis causing delay diagnosis hindering timely management condition thereupon affecting global marketplace negatively through restricted patient pool opting specialized therapy procedures henceforth hampering revenue generation
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Gastrointestinal Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Gastrointestinal Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 India Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 India Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.6 India Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 India Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2021 & 2031F |
4 India Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Gastrointestinal Drugs Market Trends |
6 India Gastrointestinal Drugs Market, By Types |
6.1 India Gastrointestinal Drugs Market, By Drug Category |
6.1.1 Overview and Analysis |
6.1.2 India Gastrointestinal Drugs Market Revenues & Volume, By Drug Category, 2021-2031F |
6.1.3 India Gastrointestinal Drugs Market Revenues & Volume, By Antiemetic, 2021-2031F |
6.1.4 India Gastrointestinal Drugs Market Revenues & Volume, By Acid Neutralizers, 2021-2031F |
6.1.5 India Gastrointestinal Drugs Market Revenues & Volume, By Anti-inflammatory, 2021-2031F |
6.1.6 India Gastrointestinal Drugs Market Revenues & Volume, By Laxatives & Antidiarrheal, 2021-2031F |
6.1.7 India Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Gastrointestinal Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Gastrointestinal Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 India Gastrointestinal Drugs Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 India Gastrointestinal Drugs Market Revenues & Volume, By Rectal, 2021-2031F |
6.3 India Gastrointestinal Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Gastrointestinal Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.3 India Gastrointestinal Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
6.3.4 India Gastrointestinal Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4 India Gastrointestinal Drugs Market, By Disease Types |
6.4.1 Overview and Analysis |
6.4.2 India Gastrointestinal Drugs Market Revenues & Volume, By Inflammatory Bowel Diseases, 2021-2031F |
6.4.3 India Gastrointestinal Drugs Market Revenues & Volume, By Gastroesophageal Reflux Diseases, 2021-2031F |
6.4.4 India Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 India Gastrointestinal Drugs Market Import-Export Trade Statistics |
7.1 India Gastrointestinal Drugs Market Export to Major Countries |
7.2 India Gastrointestinal Drugs Market Imports from Major Countries |
8 India Gastrointestinal Drugs Market Key Performance Indicators |
9 India Gastrointestinal Drugs Market - Opportunity Assessment |
9.1 India Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
9.2 India Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 India Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2021 & 2031F |
10 India Gastrointestinal Drugs Market - Competitive Landscape |
10.1 India Gastrointestinal Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |